The Brain Is the Frontier: Inside the Trial That’s Rewriting the CAR-T Playbook for Glioblastoma
A Phase 1 trial delivers B7-H3-targeting CAR-T cells directly into the brain of recurrent GBM patients — and the...
A Phase 1 trial delivers B7-H3-targeting CAR-T cells directly into the brain of recurrent GBM patients — and the...